Miller, Benjamin Francis
- Oklahoma Medical Research Foundation (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,187
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#4,187
By linked amount among FY2023 PIs
Earliest Year Loaded
2009
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Miller, Benjamin Francis as a PI. Multi-PI records show the full award amount for context.
- 5R01AG074551-02R01Contact PIDissecting the integrated mechanisms of protein turnover to prevent proteostatic decline with aging$700Kaward amount
- 5R01AG074502-02R01Contact PIDetermining the context specificity of metformin treatment on muscle mitochondria and healthspan$614.4Kaward amount
- 5R01AG064951-04R01Contact PIDoes insulin sensitivity impact the potential of metformin to slow aging?$566.7Kaward amount
Award organization
Organizations that administered FY2023 awards listing Miller, Benjamin Francis as a PI.
FY2023 award administered by Oklahoma Medical Research Foundation (OK).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardOklahoma Medical Research Foundation
- 2012R01 Grant Holder
- 2013$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #3836
- 2022Entered Top 25% NationallyRanked #3836
- 2023$5M Cumulative Funding